This combined report offering allows customers of Kalorama research to have two titles, combining Kalorama's authoritative volume covering the entire world POC market with its more focused report on molecular POC systems.
The World Market for Point of Care (POC) Diagnostics presents current analysis of the POC diagnostics industry and the role it plays in medical practice. This report takes an in-depth look at the POC diagnostic testing market, both professional and self-testing.
The report provides data on the size and growth of the following POC market segments:
• Blood Glucose Tests
• Blood and Electrolytes Testing Market
• Rapid Coagulation
• Rapid Cardiac Markers
• Substance Abuse Testing
• Pregnancy and Fertility Testing
• Colon Cancer Screening/Fecal Occult Blood Testing
• Infectious Disease Testing
• Cholesterol Testing
• Cancer Testing
• Urine Strip Testing
• Miscellaneous POC Testing
The World Market for Point of Care (POC) Diagnostics presents the main issues and trends affecting this market, influencing its move into the future. These include:
• Reimbursement Challenges
• POC and Biosensors
• POC Connectivity
• The Emergence of Non-invasive Technologies
Point-of care diagnostics using molecular technology were once discussed as a possibility in the future. That is no longer the case as many systems enter the market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world.
The Market and Potential for Molecular Point of Care Diagnostics examines the major segments of molecular POC diagnostics, exploring in-depth both current sales and market opportunity.
Kalorama's report details the companies in the market and products offered. It provides specific market size estimates for a number of segments in testing, including: respiratory tract infections, STDs, women's health, High Burden Diseases, HAI, Cancer and Other Testing.
To learn more about this industry, purchase The Market and Potential for Molecular Point of Care Diagnostics.
PDFs of both of these reports are provided as part of this offering.